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I. PENICILLIUM CHRYSOGENUM AND SECONDARY 
METABOLISM
Since the discovery of penicillin by alexander Fleming in the filamen-
tous fungus Penicillium notatum, the genus Penicillium has been deeply 
studied due to its capacity to produce a wide range of secondary me-
tabolites, many of them with biotechnological and pharmaceutical 
applications. P. chrysogenum (also identified as P. rubens) is the most 
relevant member of more than 354 species that integrate the genus 
(Nielsen et al., 2017). This species is usually found in indoor environ-
ments and associated with food spoilage. It is known as an industrial 
producer of β-lactams in particularly penicillin, and current produc-
tion strains result from several decades of classical strain improve-
ment (CSI) (Gombert et al., 2011; houbraken et al., 2011). The CSI pro-
gram began in 1943 with the isolation of P. chrysogenum Nrrl 1951 
capable of growing in submersed cultures. This strain was subjected 
to a long serial process of single spore selection, mutations induced 
by 275 nm ultraviolet and X-ray irradiation, nitrogen mustard gas and 
nitroso- methyl guanidine exposure and selection for loss of pigments 
and improved growth in large scale industrial fermenters. CSI pro-
grammes were developed in several companies (Barreiro et al., 2012), 
and this has resulted in an increase of penicillin titers by at least three 
orders of magnitude (van den Berg, 2010). as consequence, numerous 
genetic modifications were introduced in P. chrysogenum. Some have 
been studied in detail, most notably the amplification of the penicil-
lin biosynthetic clusters and DNa inversions in this region (Barreiro 
et al., 2012). although the CSI had a major impact on the production 
of β-lactams by P. chrysogenum, it also affected other secondary me-
tabolism. Genome sequencing of P. chrysogenum Wisconsin 54-1255 
revealed the presence of several further secondary metabolite gene 
clusters in addition to the penicillin cluster, most of which have poorly 
been studied and remain to be characterized (Figure 1). The products 
of the gene clusters are either nonribosomal peptides, polyketides or 
hybrid molecules.
P. chrysogenum produces a broad range of secondary metabolites 
such as roquefortines, fungisporin (a cyclic hydrophobic tetrapeptide), 
siderophores, penitric acid, ω-hydroxyemodin, chrysogenin, chrysogine, 






































II. PolykETIDES aND PolykETIDE SyNThaSES
ability to produce compounds not detected before. however, for most 
of these compounds, the responsible genes are unknown. The devel-
opment of new bioinformatics tools (SMUrF, antiSMaSh) and the in-
crease in the number of fungal genomes sequenced has opened the 
possibility to discover new natural products with novel properties (ge-
nome mining), The genes involved in the biosynthesis, regulation and 
transport of secondary metabolites tend to be arranged in the genome 
in Biosynthetic Gene Clusters (BGCs). Importantly, these gene clusters 
include the core biosynthetic genes which either encode polyketide 
synthases (PkSs), non-ribosomal peptide synthetases (NrPSs) or ter-
pene synthases genes (Smanski et al., 2016). recently, a global analysis 
was performed on 24 genomes of Penicillum species and this identified 
1317 putative BGCs predominating subdivided in two classes based 
on PkS (467) and NrPS (260) (Nielsen et al., 2017). In P. chrysogenum 
there are 33 core genes that encode 10 NrPS, 20 PkS, 2 hybrid NrPS-
PkS and 1 dimethyl-allyltryptophan synthase (van den Berg et al., 2008; 
khaldi et al., 2010; Medema et al., 2011; Samol et al., 2016) ( Figure 1), 
large number of PkS and NrPS enzymes are found also in other Peni-
cillium species but only part of these gene clusters overlap, which sug-
gests an unexplored potential of the secondary metabolome even in 
a single genus. here, we discuss the individual BGCs that have been 
identified and characterized in P. chrysogenum with a focus on those 
encoding polyketides. 
II. POLYKETIDES AND POLYKETIDE SYNTHASES
Polyketides were discovered in 1883 by James Collie, although the in-
terest in these compounds (enzymes) was revived only as late as the 
1950s by the work of arthur Birch on the aromatic polyketide-6- methyl 
salicylic acid from P. patullum. These molecules are a class of natural 
products, that may display different types of biological activities such 
as antibiotic (erythromycin a), antifungal (amphotericin B), immuno-
suppressant (rapamycin), antitumor (geldanmycin) and hypolipidemic 
agents (lovastatin) (Nair et al., 2012; Jenner, 2016; Weissman, 2016). 
Their assembly process is similar to that in fatty acid biosynthesis, al-
beit the main difference is the optional full reduction of the β-carbon 
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Isopenicillin N (1) Penicillin K (2) Penicillin G (3) Penicillin V (4)
HTD (5) DHTD (6) Meleagrin (7)
Glandicoline B (9) Roquefortine C (10) Roquefortine D (11)
Roquefortine M (13) Roquefortine N (14) Neoxaline (15)
Coprogen (16)




Figure 1. Chromosomal localization of known and predicted PKS and NRPS 
genes and secondary metabolites identified in Penicillium chrysogenum. A) 
Chromosomal localization of PKS and NRPS genes. Blue and red lines indi-



























































































































































Sorbicillin (20) Sorbicillinol (21) Dihydrosorbicillin (22) Dihydrosorbicillinol (23)
Oxosorbicillinol (24) Sorrentanone (25) Sohirnone A (26) Sihirnone B (27)
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Sorbicillactone A (40) Sorbicillactone B (41) Hydroxyemodin (42) Emodic acid (43)
























tures of secondary metabolites produced by P. chrysogenum. Adapted from (Ali 
et al., 2013; Ries et al., 2013; Salo et al., 2015; Salo, 2016; Samol et al., 2016; 






































II. PolykETIDES aND PolykETIDE SyNThaSES
the biosynthesis of polyketides are referred to as polyketide synthases 
(PkSs) (keller et al., 2005; Caffrey, 2012). 
In addition to the non-ribosomal peptide synthetases (NrPS), PkSs 
are the main enzymes that build the structural scaffold of a wide 
range of secondary metabolites and natural products in plants, bac-
teria, insects and fungi (Brakhage, 2012; Nair et al., 2012). Usually, 
these enzymes are encoded by genes that are grouped into clusters, 
that also specify genes encoding tailoring enzymes (oxygenases, ox-
idoreductases, reductases, dehydrogenases and transferases), that 
further modify the scaffold produced by the PkS into a final product 
( Brakhage, 2012; lim et al., 2012). PkSs are multimodular and multi-
domain enzymes that use a specific acyl-coenzyme a (acyl-Coa; usu-
ally malonyl- Coa or methylmalonyl-Coa) as building block, and sub-
sequently catalyze a decarboxy lative Claisen-type condensation of 
ketide units (Figure 2). The basic structural architecture consists of an 
acyl carrier protein (aCP), a ketosynthase (kS) and an acyltransferase 
(aT) domain. These combined domains extent a linear intermediate 
by two carbon atoms. an optional set of domains (dehydratase (Dh), 
ketoreductase (kr), enoyl reductase (Er) and thioesterase (TE) may 
provide further modifications of the linear intermediate (Staunton and 
Weissman, 2001; Brakhage, 2012; Nair et al., 2012; Dutta et al., 2014). 
II.1	 ACYLTRANSFERASE	DOMAIN	(AT)
a main unit during polyketide biosynthesis is the acyltransferase do-
main that selects the start unit (malonyl-Coa or methylmalonyl-Coa) 
before it is transferred to the aCP domain for the chain elongation cy-
cle (Dunn et al., 2013). This process involves two steps, i.e., the acyla-
tion and the transfer to the ACP. The first step proceeds via nucleophilic 
attack by a catalytic serine, which is present in the GhSXhG-motif at 
the thioester carbonyl of the acyl-Coa. The reaction produces an in-
termediate and the Coa moeity is released from the active site (Jenner, 
2016). During the second step, through a ping-pong bi-bi mechanism, 
the acyl-enzyme (acyl-loaded aT) intermediate is formed, whose ester 
carbonyl is nucleophilic attacked by the thiol of the phosphopante-







II. PolykETIDES aND PolykETIDE SyNThaSES 15
II.2	 ACYL	CARRIER	PROTEIN	(ACP)
The aCP is an essential cofactor that participates in polyketide biosyn-
thesis. This protein belongs to a highly conserved carrier family, and 
consists of 70-100 amino acid residues (Byers and Gong, 2007). Struc-
turally, aCP consists of four α-helices stabilized by a hydrophobic core. 
a conserved serine residue in the (D/E)xGxDSl motif, that is localized 
to the N-terminus of helix II, plays an important role in the transition 
of the aCP from the inactive (apo) to active (holo) form. The holo-ACP 
form is generated by the phosphopantetheinyl transferase enzyme 
(PPTase) through a post-translational modification of aCP whereby a 
4’-phosphopantetheine (4’-PP) moiety from coenzyme a (Coa) is trans-
ferred to the conserved serine (Evans et al., 2008;  Jenner, 2016) result-
ing in the formation of the P-pant arm. Due to its negative charge, 
helix II acts as “recognition helix” over the positive regions on aT and 
kS domains. Thus, the aCP modulates three important events during 
polyketide biosynthesis. First, it allows the condensation during chain 
elongations since it transfers the started unit from the aT domain to 
the kS domain. Second, it shuttles the growing chain between the up 
and downstream domains, as well to optional PkS domains, probably 
involving protein-protein recognition between domains. Third, it pre-
vents premature cyclization and enolization of the polyketide chain 
(kapur et al., 2010; yadav et al., 2013).
II.3	 KETOSYNTHASE	DOMAIN	(KS)
The kS is a homodimeric condensing domain that catalyses the extension 
of the β-ketoacyl intermediate by a decarboxylative Claisen condensa-
tion. This domain contains two active sites that are accessible to the aCP 
through its flexible P-pant arm, which receives the β-carboxy acyl-Coa ex-
tender unit from the aT. at that stage, a thioester bond is formed between 
the active-site cysteine thiol of kS and the growing polyketide. only when 
both units are covalently attached onto the module, the decarboxy lative 
Claisen condensation occurs, which involves two conserved his residues. 
Therefore, mechanistically the kS domain acts at three stages: acylation, 
decarboxylation and condensation (Chen et al., 2006; Caffrey, 2012; 






































II. PolykETIDES aND PolykETIDE SyNThaSES
The kS domain may also transfer intermediates between mod-
ules without chain extension. This is the case with some kS variants, 
named kS0, that lack the active histidine involved in the polyketide 
elongation. another variant is the kSQ that has a glutamine residue 
instead of the active site cysteine. This permits loading modules from 
cis-aT PkS (Jenner, 2016). recently, a kS domain has been subjected 
to extensive protein engineering to identify alterations in and around 
the active site residues of kS, which boosts substrate promiscuity 
and activity. For instance, in the kS3 domain in the enzyme 6-deoxy-
erythronolide B synthase (DEBS), a change of an alanine to tryptophan 
in the active-site proximal dimerization loop increases the promiscuity 
of the enzyme (Bayly and yadav, 2017). 
II.4	 KETOREDUCTASE	DOMAIN	(KR)
The kr domain functions as a β-carbon processing unit that belongs 
to the family of short-chain dehydrogenase/reductases. This domain 
reduces the β-keto group, that is formed during the condensation pro-
cess, into a hydroxyl group (a β-hydroxyl intermediate) using NaDPh 
(keatinge-Clay and Stroud, 2006; Caffrey, 2012). Its catalytic activ-
ity involves three domains with conserved residues (tyrosine, lysine 
and serine) and these domains are divided in three types (a, B and C) 
according to the stereochemical result of the reduction. The a-type 
produces the levo (l) configuration of the β-alcohol group, while 
B-type denotes a dextro (D) configuration. The inactive krs repre-
sent the third category, the C-type (Caffrey, 2012; Jenner, 2016; Bayly 
and  yadav, 2017). Therefore, the stereo configuration of the α- and 
 β-carbon atoms of aCP substrates is dictated by the kr domain. ad-
ditionally, some kr domains are equipped with epimerase activity. 
The epimerizing module has a more open architecture, enabling the 
catalytic epimerization of methyl groups in acyl-aCP substrates, a re-
action that involves the conserved serine and tyrosine residues that 
are also employed during ketoreduction (ostrowski et al., 2016; Bayly 
and yadav, 2017). however, it is not obligatory that both activities, ke-
toreduction and epimerization, are present in the kr domain. Indeed, 
some kr domains only have epimerase activity (C2), while others only 
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or are catalytically inactive (C1) (annaval et al., 2015). kr domains are 
promising targets for engineering since their signature motifs can be 
used to predict the stereochemistry of the kr domains, albeit there 
are some exceptions. The most successful method for kr engineer-
ing is modification of the active site or swapping of the reductive loop 
(rlS) (kellenberger et al., 2008). 
II.5	 DEHYDRATASE	DOMAIN	(DH)
The Dh domain is usually coupled to B-type kr domains (B-type). This 
domain catalyzes water elimination (via syn or anti) at the β- hydroxy acyl 
chain position thereby producing trans double bonds (α,β- unsaturated 
moieties). It has been proposed that an aspartic acid located in the 
hPallD motif is the proton donating entity whereupon the catalytic 
histidine, in the HXXGXXP motif, eliminates an α-proton, resulting in 
unsaturation. however, when the dehydration occurs on a-type ketore-
duction products ((3S)-3-hydroxyacyl chain) a cis double bond is formed. 
The diastereospecificity nature of this domain is an important target for 
engineering. Structurally, the Dh domain consists of a central helix and 
seven β sheets which are arranged in a double hotdog fold, with one ac-
tive site. This differs from the Dh domains of fatty acid synthases (FaS) 
Dhs that may have many active sites per double hotdog fold (Caffrey, 
2012; Bruegger et al., 2014; Jenner, 2016; Bayly and yadav, 2017).
II.6	 ENOYLREDUCTASE	DOMAIN	(ER)
The Er domain is an optional tailoring unit involved in the final oxi-
dation state of the growing polyketide. It reduces α,β-enoyl groups 
and thereby generates saturated α-β bonds. This reaction involves 
NaD(P)h as hydride donor in Michael addition type of mechanism. In 
the enoyl reduction, the products formed during this reaction have a 
specific stereochemistry (3r,2r) or (3r,2S) due to the β-carbon attack 
performed by the pro-4r hydride of NaDPh, contrasting the kr do-
main that utilizes the pro-4S hydride (Chen et al., 2006; Bruegger et al., 
2014). Structurally, the Er domain belongs to the medium-chain de-






































II. PolykETIDES aND PolykETIDE SyNThaSES
monomeric state presented in the trans Er domains, highly reducing 
Er domains form dimers.
additionally, it has been reported that the stereospecificity of the 
S-configuration depends on the presence of a tyrosine in the Er do-
main that is used for the protonation of α-carbon yielding (2S)-alkyl-
branched products. Indeed, (2r) products are detected when the ac-
tive tyrosine is absent or replaced by alanine, valine or phenylalanine 
(kwan and leadlay, 2010; Bruegger et al., 2014). In fungi, the wide 
range of polyketide products mostly emerges from trans-acting Er do-
main. For instance, during the lovastatin biosynthesis lovC only re-
duces tetra-, penta- and heptaketide intermediates (ames et al., 2012). 
another example is the trans-acting Er FSl5 in Fusarielin BGC that 
acts on C10=C11 or C12=C13 to help in the synthesis of the correspond-
ing polyketide (Droce et al., 2016). 
II.7	 THIOESTER	DOMAIN	(TE)
Termination of polyketide biosynthesis involves the TE domain, which 
produces macrolactones via intramolecular cyclization or linear polyket-
ides by hydrolysis (keatinge-Clay, 2012). In both events, an acyl-TE in-
termediate is formed through the transfer of the polyketide chain from 
the last aCP to the active serine on TE domain (Jenner, 2016). In the hy-
drolysis mechanism, the active site of the TE domain (SxDxh) causes a 
nucleophilic attack on the carbonyl of the thioester, which occurs when 
the conserved asp residue is stabilized to receive a proton from the ser-
ine residue present in this motif. Stabilization is carried out when the 
histidine acts as catalytic base. During macrolactone formation, a sim-
ilar aT-mechanism is involved, although during the second half of the 
reaction the acyl component of the acyl-enzyme intermediate gives the 
nucleophile needed during the reaction. This occurs when a secondary 
alcohol/amine is activated by the catalytic histidine to perform he ester 
attack and release the cyclic product (keatinge-Clay, 2012; Bruegger 
et al., 2014). The TE domain consists of around 270 residues and has 
an α,β-hydrolase fold (acting in cis or trans) or the hot-dog fold. Typi-
cally, the TE domain in modular type I PkS systems is dimeric and the 
iterative type I PkS is monomeric (Jenner, 2016). Usually, TE domains 
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also the case for special TE domains such as the TE/ClC (Claisen-like 
cyclase) type, which is implicated in the formation of a new ring system 
during the biosynthesis of aflatoxin and naphthopyrone (keller et al., 
2005; Nakamura et al., 2015).
II.8 POLYKETIDE SYNTHASE CLASSIFICATION
according to their protein architecture and mode of action, PkS en-
zymes are classified into three types.
Type I PKSs are mainly found in bacteria and fungi. These multido-
main proteins can be further subdivided in two categories: modular 
and iterative (Nair et al., 2012). Modular type I PKSs or non-iterative 
PKSs are unique for bacteria and are characterized by presenting a se-
quence (or set) of modules, each constituted with set of specific cata-
lytic domains. In consequence, the number of precursors fused in the 
polyketide is equivalent with the number of modules that are pres-
ent (Chan et al., 2009). The 6-deoxyerythronolide B synthase (DEBS), 
which catalyzes the synthesis of the aglycone core in erythromycin a 
(Figure 2a), is a representative example of this category since during 
the chain extension each cycle is performed by a different module 
(kellenberger et al., 2008; Stevens et al., 2013). In contrast, iterative 
type I PKSs use the same catalytic core domains as modular type I 
PkSs, but the catalytic reaction is repeated to yield the complete 
polyketide backbone. a representative example of this type is lovB, 
that together with lovC (a enoyl reductase) catalyzes around 35 re-
actions to produce dihydromonacolin l, an intermediate in lovastatin 
biosynthesis (Campbell and Vederas, 2010). 
Type II PKSs are unique for bacteria and use a similar iterative mech-
anism as observed in iterative type I PKSs. however, the different cat-
alytic domains are encoded by independent genes. In general, they 
often constitute a “minimal PkS”, that comprises two kS units (kSα 
and kSβ) and an aCP protein that holds the growing PkS chain (Fig-
ure 2D). The kSβ domain defines the length of the polyketide chain. 
The folding pattern of the poly-β-keto intermediates is determined by 
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other tailoring modifications are performed by oxygenases, methyl 
and glycosyl transferases. known metabolites synthetized by type II 
PkSs are tetracyclines, anthracyclines and aureolic acids (hertweck 
et al., 2007; Jenner, 2016).
Type III PKSs have originally been discovered in plants, but are also 
present in bacteria and fungi. They consist of a single kS domain that 
catalyzes a defined number of elongations (Figure 2E), usually gener-
ating small phenols or naphtol rings. The enzyme transfers the acyl 
group from the Coa to the active site histidine, which is a highly con-
served residue. however, the amino acid sequence of the his motif 
is not similar to those found in kS domains of type I and II PkS en-
zymes (Shen, 2003; Chan et al., 2009; Bruegger et al., 2014; Jenner, 
2016). Importantly, independent of the mechanistic or structural dif-
ferences, all the polyketides synthetized by PkS enzymes follow the 
same decarboxylative condensation mechanism of the acyl Coa pre-
cursors. however, these precursors should prior be activated by the 
aCP domain, in the case of the type I and II PkS enzymes, whereas 
type III PkS enzymes act independently of aCP domain (Shen, 2003; 
 Weissman, 2009). acridones, pyrenes, chalcones are some examples 
of the compounds produced by type III PkS enzymes (yu et al., 2012).
II.8.1 FUNGAL ITERATIVE PKSS
like type I PkS enzymes, fungal PkSs have a modular organization and 
the consecutive domains act in sequential order during the synthesis 
of the complete polyketide. They are equipped with basic structural 
domains typically found in PkS enzymes (aCP-kS-aT domains) but 
may also contain optional units (kr,Dh,Er,TE domains). Depending 
Figure 2. Polyketide processing elements. A) Modular Type I PKS. Erythro-
mycin biosynthesis. B) Elongation and reduction process for Iterative Type I 
PKS (fungal). C) NR-PKS domain structure of Iterative Type I PKS. D) Type II 
PKS: iterative mechanism. MCAT (malonyl-CoA:ACP transferase). E) Type III 
PKS: iterative and ACP- independent. For details see the text. Adapted from 
( Hertweck et al., 2007; Weissman, 2009; Campbell and Vederas, 2010; Cox 
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II. PolykETIDES aND PolykETIDE SyNThaSES
on the presence or absence of reducing domains, these enzymes can 
be divided into highly reducing (HR), non-reducing (NR) and partially re-
ducing (PR) PkS (Figure 2B–C). 
Highly reducing PKS (HR-PKS) produces the linear or cyclic scaffold of 
some compounds as fumonisins, T-toxines, solanapyrone E, squalesta-
tin, lovastatin (Chiang et al., 2014; roberts et al., 2017). Usually, they 
start with a kS domain, followed by an aT, Dh and C-Met domain, al-
though this latter not always follows the Dh domain. The Er domain 
is an optional unit in hr-PkS enzymes, but when the Er is missing, 
the corresponding region is filled with a polypeptide domain with un-
known function. Furthermore, these enzymes do not contain a product 
template domain (PT) or N-terminal SaT domain, whereas these spe-
cial domains are present in Nr-PkS enzymes (Cox and Simpson, 2010).
Partially	 reducing	 PKS	 (PR-PKS). Structurally, these enzymes have 
a domain architecture that is similar to the mammalian FaS: a N- 
terminal kS-domain followed by a aT-, Dh-, and “core”-kr-aCP do-
main. These enzymes lack an Er domain (l. Wang et al., 2015), and 
also do not have a TE domain, which suggests an alternative mech-
anism of product release than hydrolysis. Pr-PkS enzymes produce 
small aromatic molecules such as 6-methylsalicylic acid (MSa), but 
in most cases the chemical product is unknown (Cox and Simpson, 
2009, 2010; kage et al., 2015).
Non-reducing PKS (NR-PKS) are involved in the biosynthesis of aro-
matic polyketides, which contain conjugate aromatic rings. Typically, 
these enzymes consist of six catalytic domains that are covalently 
tethered and arranged in four components: loading (SAT), chain exten-
sion (KS-MAT-PT-ACP), cyclisation and processing components (TE-CLC). 
The aCP transacylase (SaT) domain acts as starter unit that loads the 
acyl carrier protein whereupon chain extension is mediated for kS and 
aT domain. During this process, the malonyl-Coa:aCP transacylase 
(MaT) domain transfers the extension units from malonyl-Coa to the 
aCP, while the product template (PT) domain stabilizes the reactive 
poly-β-keto intermediates. The processing component acts after the 
initial assembly when the cyclized or polyketide intermediate is still 
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TE/Claisen cyclase (ClC) domain. aflatoxin, orsellenic acid, griseof-
ulvin, zearalenone and bikaverin are some example of products pro-
duced by Nr-PkS. (Cox and Simpson, 2010; Crawford and Townsend, 
2010; Bruegger et al., 2013; Chiang et al., 2014).
III. POLYKETIDES OF PENICILLIUM CHRYSOGENUM
Table 1 lists all PkS genes of P. chrysogenum and insofar known the as-
sociated products.
Table 1. Polyketide synthases in P. chrysogenum and (insofar known) their associ-
ated products. ks, ketosynthase; at, acyltransferase; dh, dehydratase; mt, meth-
yltransferase; er, enoyl reductase; kr, ketoreductase; acp, acyl carrier protein; 
te/red, thioester reductase. (*) Point mutations present in pks genes of industrial 
P. chrysogenum strains subject to CSI program. Modified from Samol et al., 2016.
Gene ID Gene Name Protein Domain organization Product/Pathway
Pc12g05590 pks1 - ks-at-dh-mt-kr-acp -
Pc13g04470 pks2* - ks-at-dh-mt-er-kr-acp -
Pc13g08690 pks3 - ks-at-dh-mt-er-kr-acp -
Pc16g00370 PcYanA(pks4) 6-MSA synthase ks-at-kr-acp 6-MSA/Yanuthones
Pc16g03800 pks5 - ks-at-dh-er-kr-acp -
Pc16g04890 pks6 - ks-at-dh-mt-er-kr-acp -
Pc16g11480 pks7* - ks-at-dh-mt-er-kr-acp -
Pc21g00960 pks8* - ks-at-dh-mt-er-kr-acp -
Pc21g03930 pks9 - ks-at-dh-mt-er-kr-acp -
Pc21g03990 pks10 - ks-at-dh-er-kr-acp -
Pc21g04840 pks11 - ks-at-dh-er-kr-acp -
Pc21g05070 SorB(pks12)* Sorbicillin synthase ks-at-acp-mt-te/red Sorbicillinoids
Pc21g05080 SorA(pks13)* Sorbicillin synthase ks-at-dh-mt-er-kr-acp Sorbicillinoids
Pc21g12440 pks14 - ks-at-dh-er-kr-acp -
Pc21g12450 pks15* - ks-at-acp-te -
Pc21g15160 pks16 - ks-at-dh-mt-er-kr-acp -
Pc21g16000 PcAlb1(pks17)* YWA1 synthase ks-at-acp-acp-te YWA1/DHN-Melanin
Pc22g08170 PcPatK(pks18) 6-MSA synthase ks-at-kr-acp 6-MSA/Patuline
Pc22g22850 AdrD(pks19) DMOA synthase ks-at-acp-mt-te/red DMOA/Andrastin A






































III. PolykETIDES oF PENICIllIUM ChrySoGENUM
III.1 SORBICILLINOIDS
Sorbicillinoids are yellow pigments that already during the earlier stages 
of the CSI programme were eliminated from P. chrysogenum, since they 
interfered as a colored contamination during antibiotic production. 
however, in recent years the interest in this group of molecules has 
revived due to the pharmacological activities of some sorbicillinoids. 
These compounds belong to a family of hexaketide metabolites that 
were originally isolated from P. notatum in 1948. More than 90 mol-
ecules have been detected in a range of fungi such as Trichoderma, 
Emericella, Acremonium, Verticillium and some marine ascomycetes 
(harned and Volp, 2011; Salo et al., 2015; Meng et al., 2016). Structur-
ally, the sorbicillinoids are highly oxygenated molecules with bicyclic 
and tricyclic ring skeletons (structures). The C1’–C6’ sorbyl side chain 
is a typical feature present in the sorbicillinoids. These structures are 
produced by oxidative dearomatization, dimerization/tridimerization 
of sorbicillin and modifications introduced by rearrangement reactions 
(Bringmann et al., 2005; Meng et al., 2016). Therefore, these mole-
cules can be grouped as monomeric sorbicillinoids, bisorbicillinoids, 
trisorbicillinoids and hybrid sorbicillinoids (Meng et al., 2016). 
Sorbicillinol is the most common and reactive form of the mono-
meric sorbicillinoids, and is a key pathway intermediate (Fahad, 2014). 
For instance, sorbicillinol can be converted to bisvertinolone through 
a nucleophilic attack from the carbanion (formed in oxosorbicillinol) 
to C-1 in sorbicillinol. additionally, sorbicillinol is also the precursor 
of two bisorbicillinoids: bisorbicillinol and trichodimerol (N. abe et al., 
2002). These compounds respectively exhibit an antioxidant effect 
and indirectly inhibit the tumor necrosis factor-α (TNF-α) ( Sugaya 
et al., 2008). overall, monomeric and dimeric sorbicillinoids have a 
radical-scavenging activity, albeit some bisorbicillinoids show antimi-
crobial and anticancer activities. recently, some sorbicillinoids have 
been described that act as potential inhibitors of target proteins asso-
ciated with diabetes and hIV (Du et al., 2009; harned and Volp, 2011).
regarding the sorbicillinoids biosynthesis, isotope labelling stud-
ies showed that the formation of the hexaketide structure of sorbi-
cillinol is performed by a Claisen-type reaction (Sugaya et al., 2008; 
harned and Volp, 2011). Further sorbicillinoid dimers are assembled 
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et al., 2009). likewise, in P. chrysogenum E01-10/3, two polyketide 
synthases were suggested to be involved in the synthesis of sorbicil-
lactone a/B (avramović, 2011). In P. chrysogenum, it was demon-
strated that Sora, a highly reducing polyketide synthase, is essential 
for sorbicillinoid biosynthesis (Salo et al., 2016). Interestingly, this PkS 
gene belongs to a gene cluster that contains another PkS gene and 
this gene cluster is also found in some Hypocreales. While in Colletotri-
chum graminicola only the two polyketide synthases genes are pres-
ent. P. chrysogenum contains a cluster of seven genes, which includes 
the two polyketide synthases (sorA, Pc21g05080; sorB, Pc21g05070), 
two transcriptional regulators, a transporter of the major facilitator 
superfamily (MFS), one monoxygenase and one oxidase. Despite the 
fact that this cluster is also present in industrial improved strains of 
P. chrysogenum, these strains do not produce sorbicillinoids due to a 
point mutation in the ketosynthase domain of Sora (Druzhinina et al., 
2016; Salo et al., 2016). recently, the biosynthetic pathway and reg-
ulatory mechanism have been resolved, wherein sorbicillinoids act as 
autoinducers (Guzmán- Chávez et al., 2017).
III. 2 ω-HYDROXYEMODIN
ω-hydroxyemodin (ohM), also called citreorosein, is a bright- yellow 
pigment isolated of P. cyclopium. This compound is a derivative of 
emodin, which is a molecule common for terrestrial Penicillium strains 
(Fouillaud et al., 2016; Samol et al., 2016). recently, It was demon-
strated that ohM inhibits quorum sensing involved in the production 
of virulence factors in Staphylococcus aureus by direct binding of ohM 
to the regulatory protein. Interestingly, ω-hydroxyemodin was isolated 
from solid cultures of P. restrictum (Daly et al., 2015). likewise, ohM 
reduces the production of proinflammatory cytokines in mast cells, 
which play an important role in the inflammatory and hypersensitiv-
ity response during the immune response (lu et al., 2012). It has been 
suggested that P. chrysogenum is also able to produce ohM, since 
this compound was detected in cultures of P. citreoroseum, a strain 
that was later identified as P. chrysogenum (rajagopalan and Seshadri, 
1956; houbraken et al., 2011). ohM is an anthraquinone, that like 






































III. PolykETIDES oF PENICIllIUM ChrySoGENUM
biosynthesis seems to occur through the acetate-malonate pathway in-
volving non-reducing polyketide synthases (Brase et al., 2009;  Fouillaud 
et al., 2016). In the case of ω-hydroxyemodin, the genes involved in its 
synthesis have not been identified yet. 
III.	3		 6-METHYLSALYCILIC	ACID	(6-MSA)
6-MSa is one of the smallest polyketides, whose structure contains 
a cyclized eight carbon chain. This molecule is produced by 6- methyl 
salicylic acid synthase (6-MSa synthase), a partial reducing PkS 
( Wattanachaisaereekul et al., 2007; Gallo et al., 2013). This enzyme con-
tains a kS, MaT, Dh, kr and aCP domain, which are responsible to as-
semble three molecules of malonate and one molecule of acetate into 
6-MSa by a sequence of reactions in the following order: two conden-
sation reactions, a reduction, a dehydration, a third condensation, and 
cyclisation reaction and the release of the final molecule (Staunton and 
Weissman, 2001). P. chrysogenum contains two PkS genes that encode 
for 6-MSa synthases. These genes belong to different BGCs involved 
in the biosynthesis of the mycotoxin patulin (Pc22g08170) and the an-
tibiotic yanuthone D (Pc16g00370). The synthesis of these molecules 
involves three common steps. Despite the fact that these two BGCs 
are highly conserved in the Penicillium genus, some species only har-
bor one cluster, while others such as P. chrysogenum only contains a 
full version of one cluster (yanuthone D BGC), while the second cluster 
(patulin BGC) is incomplete (Nielsen et al., 2017). Indeed the absence 
of the gene encoding for isoepoxidon dehydrogenase in P. chrysogenum 
agrees with the fact that this fungi does not produce patuline (Samol 
et al., 2016). however, under laboratory conditions yanuthone D is also 
not detected in this fungus (Salo, 2016).
III. 4  YWA1
The heptaketide naphthopyrone yWa1 is a pigment present in spores 
which provides rigidity and impermeability to the cell wall (Crawford 
and Townsend, 2010). In Aspergillus nidulans, yWa1 is produced by 
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cyclization and aromatization of the first ring (Cox, 2007). Interest-
ingly, the TE-ClC domain in other Nr-PkSs is responsible for the syn-
thesis of compounds such as norsolorinic acid, anthrone and bika-
verin. Indeed, when the carboxy-terminal TE domain is removed from 
WaS, citreoisocoumarins is produced instead of yWa1(Crawford and 
Townsend, 2010). In A. fumigatus, the protein alb1P is an orthologue 
protein of WaS. This corresponding gene belongs to the melanin BGC 
that is expressed during the conidiation process. During the biosyn-
thesis of melanin, the product formed by alb1P (yWa1) is converted 
to 1,3,6,8 tetrahydroxynaphtalene (ThN) by ayg1p through a retro 
Claisen mechanism. after the reduction of ThN by arP2, a dehydra-
tion step is performed by the enzymes encoded by the arp1 and abr1 
genes that encode scytalone and vermelone dehydratases, respec-
tively. The final polymerization is catalysed by a laccase (encoded by 
the abr2 gene) that converts 1,8-DhN into DhN-melanin (Pihet et al., 
2009). In P. chrysogenum, the orthologue genes involved in the mela-
nin biosynthetic pathway are: pks17 (Pc21g16000), ayg1 (Pc21g16440), 
abr1 (Pc21g16380), apr1 (Pc21g16420), arp2 (Pc21g16430), and abr2 
(Pc22g08420). however, these genes are only partially clustered in 
the genome (Salo, 2016). 
III. 5  ANDRASTIN A
andrastin a is a metabolite produced by several species from the 
Penicillium genus. It is a potential antitumor agent and functions as a 
farnesyl transferase inhibitor (overy et al., 2005; Matsuda et al., 2013). 
recently, the andrastin a biosynthetic gene cluster has been described 
in P. roqueforti and P. chrysogenum. This BGC consists of eleven genes 
designated adrA-J (Pc22g22820 to Pc22g2292), that encode for a cy-
tochrome P450, hypothetical protein, aBC transporter, polyketide syn-
thatase, ketoreductase, short chain dehydrogenase, prenyltransferase, 
FaD-dependent monooxygenase, terpene cyclase, acetyltransferase 
and methyltransferase, respectively (Matsuda et al., 2013; rojas-aedo 
et al., 2017). adrD (PkS 19) is a PkS that catalyse the first reaction to 
produce a tetraketide (3,5-dimethylorsellinic acid, DMoa) from acetyl 
Coa, malonyl Coa and S-adenosylmethionine. The following steps in 
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and adrh to produce the epoxyfarnesyl-DMoa methyl precursor. Us-
ing a heterologous co-expression approach in Aspergillus oryzae, the 
pathway has been resolved, although the role of adrB and adrC is un-
known (rojas-aedo et al., 2017). Interestingly, P. chrysogenum strains 
that were subject to CSI are not able to produce andrastin a or any 
related compound. 
IV. STRATEGIES TO ACTIVATE SILENT GENE CLUSTERS
Natural products represent a broad range of molecules produced by 
animals, plants and microorganisms. These molecules may display dif-
ferent biological activities (e.g. antiviral, antimicrobial, anti-tumor, im-
munosuppressive agents) and it is estimated that the majority of these 
compounds are derived from filamentous fungal sources and from fil-
amentous bacteria belonging to the genus Streptomyces. With respect 
to antibiotics, most of the chemical scaffolds used today were discov-
ered during the golden age of antibiotics discovery (1940s–1960s). 
This was followed by four decades during which hardly any new scaf-
folds from a natural source were developed (reen et al., 2015;  Smanski 
et al., 2016; okada and Seyedsayamdost, 2017). however, there is 
also a current understanding that only a small fraction of the potential 
possible molecules has been discovered to this date. This follows from 
genomic studies revealing large numbers of uncharacterized BCGs, 
while many of these gene clusters are not expressed (silent or sleeping 
gene clusters) under laboratory conditions (Brakhage and Schroeckh, 
2011). Furthermore, metagenomics studies indicate that the majority 
of microbes present in the environment have not been cultured and 
characterized. Thus, there are many challenges that need to be over-
come in order to harness the natural diversity of natural products, to 
cultivate potential strains under laboratory conditions and activating 
the BGCs for expression. To achieve the latter, two main approaches 
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IV.1 MANIPULATION OF CULTIVATION CONDITIONS 
Under natural conditions, fungi face a variety of biotic and abiotic condi-
tions to survive. The cellular response to the environment involves com-
plex regulatory networks that respond to stimuli such as light, ph, avail-
ability of carbon and nitrogen sources, reactive oxygen species, thermal 
stress, and interspecies-crosstalk (Brakhage, 2012; reen et al., 2015). 
OSMAC (one strain many compounds) approach. This strategy is de-
rived from the observation that changes in the metabolic output of 
microorganisms can be achieved by alternating the medium compo-
sition and other cultivation parameters. It is well known that glucose, 
ammonium or phosphate at high concentrations act as repressors of 
secondary metabolism, whereas iron starvation and nitrogen limita-
tion can stimulate secondary metabolite production. The latter is for 
instance exploited for the production of terrain by A. terreus (Bode 
et al., 2002; Brakhage and Schroeckh, 2011; Gressler et al., 2015). This 
strategy can readily be implemented using high-throughput methods, 
where an array of culture conditions can be screened for new me-
tabolite profiles (Spraker and keller, 2014). In combination with bio-
informatics tools, this strategy can be a powerful tool to investigate 
the production of new molecules, as exemplified by the discovery of 
aspoquinolones a–D in A. nidulans (Scherlach and hertweck, 2006). 
however, despite the fact that the oSMaC approach has led to the 
discovery of increased numbers of new molecules with antimicrobial 
activity, some chemical and physical conditions are still missing under 
the laboratory tested conditions as often the activation concerns a 
limited number of BCGs (Chiang et al., 2009). 
Interspecies-crosstalk. The production of secondary metabolites is a nat-
ural strategy that microorganisms have developed to cope with spe-
cific environmental conditions and challenges. They serve as interme-
diary agents to stablish a symbiotic association between species or as 
a weapon against other organism to compete for nutrients and space. 
These conditions, that are not present in axenic cultures, boost the pro-
duction of molecules that are constitutively present and/or that are 
cryptic and normally are not synthetized due to silencing of the respec-
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in which different organisms are cultivated together is called “co- culture”, 
which has been successful in several cases yielding new metabolites. 
A. fumigatus produces fumiformamide when co-cultivated with Strep-
tomyces peucetius, while co-cultivation of this fungi with Streptomyces 
rapamycinicus results in the production of fumicyclines a and B, two 
novel polyketides with antibacterial activity, are examples of the use of 
this strategy (Netzker et al., 2015; adnani et al., 2017). Interestingly, the 
association of two marine organisms, Emericella sp and Salinispora aren-
icola, results in the biosynthesis of emericellamides a and B which are 
equipped with antibacterial activity (oh et al., 2007). also, the interac-
tions between fungi and insects result in the production of volatile sec-
ondary metabolites (rohlfs and Churchill, 2011).
IV.2 GENETIC INTERFERENCE
another mechanism to stimulate the expression of silent BGCs is by 
genetic interference, for instance by direct manipulation of the regu-
latory network related to BCGs expression. The regulation of BGCs is 
effected at many levels, through specific (or local) and global regula-
tors up to epigenetic regulation involving the modification of the chro-
matin landscape (lim et al., 2012; Spraker and keller, 2014).
IV.2.1 MANIPULATION OF GLOBAL REGULATORS
Pleiotropic transcriptional regulators or global regulators are proteins 
that respond to environmental signals such as ph, temperature, and N- 
and C-sources. They provide the link between the production of sec-
ondary metabolites and external cues. In fungi, these proteins control 
the regulation of BGCs that do not contain other regulatory factors. 
about half of the known clusters do not encode a local and specific 
regulator. additionally, global regulators also act over genes that do 
not belong to secondary metabolism (Brakhage, 2012; rutledge and 
Challis, 2015; Fischer et al., 2016). Global regulators that have been 
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Velvet complex. This heterotrimeric complex is a conserved regulator 
present in most of the fungi, except yeast. It consists of at least three 
proteins: Vea, VelB and laea. likewise, this complex provides a link 
between sexual development and secondary metabolism through light 
regulation (yin and keller, 2011; Deepika et al., 2016), since light has 
an inhibitory effect on Vea expression. The formation of the velvet 
complex takes place in the nucleus, where the complex Vea-VelB via 
the α-importin kapa meets the methyltransferase laea. It has been 
hypothesized that the velvet complex acts as a transcriptional factor 
as it contains a DNa binding fold that resembles the corresponding re-
gion of the NF-κB transcription factor of mammals (Sarikaya- Bayram 
et al., 2015). The role of the velvet complex in secondary metabolism 
mostly follows from the control that the laea protein executes on 
several BGCs in filamentous fungi. laea (loss of aflr expression-a) 
was identified in 2004 as a global regulator in Aspergillus. Deletion of 
this gene results in the repression of many BGC, such as the one re-
sponsible for the production of penicillin, lovastatin and sterigmato-
cystin. overexpression of laea causes an opposite phenotype. Inter-
estingly, laea is negatively regulated by aflr ( Zn2Cy6 transcriptional 
factor) in a feed loop mechanism (Bok and keller, 2004). It has been 
hypothesized that laea acts at different levels, i.e., as a methyltrans-
ferase, epigenetically and as a direct member of the velvex complex. 
Structurally, laea has a S-adenosyl methionine (SaM)-binding site 
with a novel S-methylmethionine auto-methylation activity, although 
this activity does not seem to be essential for its function. laea is 
not a DNa- binding protein, but it does affect chromatin modifications. 
In an A. nidulans ΔlaeA strain, high levels of the heterochromatin pro-
tein 1 (hepa) are detected and an increase in trimethylation of the 
h3k9 in the sterigmato cystin cluster. When laea is present, the lev-
els of hepa, ClrD (h3k9 methyltransferase) and h3k9me3 decrease 
while the sterigmato cystin levels are raised. The heterochromatic 
marks stay until the sterigmato cystin cluster is activated, and appar-
ently laea influences the offset of these marks in this particular cluster 
(reyes-Dominguez et al., 2010;  Brakhage, 2012; Jain and keller, 2013; 
Sarikaya-Bayram et al., 2015; Bok and keller, 2016). orthologues of 
laea have been discovered in many other filamentous fungi as Penicil-
lium, Fusarium, Trichoderma, Monascus spp and laea exhibits positive 
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laea1 of Fusarium fujikuroi positively regulates the production of fusa-
rin C, fumonisins and gibberellins, and represses bikaverin biosynthesis. 
In P. chrysogenum, laea controls the biosyhthesis of penicillin, pigmen-
tation and sporulation. In Trichoderma ressei, lae1 positively modu-
lates the expression of celullases, xylanases, β- glucosidases. Interest-
ingly the stimulation of these genes was not directly influenced by the 
methylation of h3k4 or h3k9 (Wiemann et al., 2010; yin and keller, 
2011; lim et al., 2012; Seiboth et al., 2012; Jain and keller, 2013). 
laea is not the only member of the velvet complex that has influ-
ence on the regulation of secondary metabolite production. VeA of 
A. parasiticus is necessary for the expression of two transcriptional fac-
tors of the aflatoxin cluster (aflr and aflJ), which regulate the pathway. 
In Aspergillus fumigatus, vea regulates twelve BGCs (Dhingra et al., 
2013). This study also revealed that vea modulates the biosynthesis 
of fumagillin via the regulation of fumr, a transcriptional factor of the 
fumagillin cluster, which in turn is also regulated by laea. Similarly, a 
transcriptome analysis in A. flavus revealed that 28 of 56 BGCs are 
dependent on veA, in particular the aflavarin cluster which is differen-
tially expressed. likewise, orthologues of vea are also present in other 
fungi such as in P. chrysogenum, Fusarium oxysporum, Botrytis cinerea, 
Fusarium verticillioides (yin and keller, 2011; Dhingra et al., 2013; Jain 
and keller, 2013; Cary et al., 2015). Despite the clear interaction be-
tween vea and laea in the velvet complex and its influence on sec-
ondary metabolism, it is thought that vea may be acting as molecular 
scaffold of the velvet complex, since it interacts with other three me-
thyl transferases (laea-like methyltransferase F (llmF), velvet inter-
acting protein C (VipC), and VipC associated protein B (VapB)). This 
suggests that vea functions in a supercomplex or in dynamic network 
control. Taken together, modulation of the velvet complex is a useful 
tool to activate BCGs (Sarikaya-Bayram et al., 2015).
bZIP	transcription	factors are highly conserved in the eukaryote domain. 
The dimeric basic leucine zipper (bZIP) transcriptional factors play an 
important role in the cellular responses to the environment. regard-
ing the structure, they contain a conserved leucine zipper domain and 
a basic region, which controls the dimerization of the protein and es-
tablishes sequence-specific DNa-binding, respectively. once dimeric, 
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and phosphorylation (amoutzias et al., 2006; knox and keller, 2015). 
In fungi, bZIP proteins have been implicated in multiple metabolic pro-
cesses, such as in the regulation of development, morphology and in 
stress responses. Several orthologues of the yap family bZIPs, which 
were first described in yeast, have been characterized in Aspergillus 
spp (atfa, Napa, afyap1, aoyap1, and apyap1) and these regulators 
have recently been associated with the production of secondary me-
tabolites in filamentous fungi. In A. nidulans, overexpression of RsmA 
(restorer of the secondary metabolism a, yap-like bZIP) has a com-
pensatory effect on secondary metabolism in a strain in which laea 
and vea are missing. however, these transcription factors also display 
negative regulation. For instance, an increase in the biosynthesis of 
aflatoxin and chratoxin has been observed when yap1 is deleted in A. 
parasiticus and A. ochraceus (yin et al., 2013; knox and keller, 2015; 
X. Wang et al., 2015). MeaB is another bZIP transcriptional factor that 
was discovered in A. nidulans. Its function is associated in nitrogen 
regulation and has a negative effect on the biosynthesis of aflatoxin in 
A. flavus and bikaverin production in F. fujikuroi. (Wagner et al., 2010; 
amaike et al., 2013).
Other global regulators. area is a highly conserved transcriptional fac-
tor in fungi that belongs to the GaTa family and it is characterized by 
Cys2hys2 zinc finger DNa binding domains. likewise, it is involved in 
the repression of nitrogen metabolism when ammonium or glutamine 
are present. recently, this transcription factor and its orthologues 
have been shown to influence secondary metabolism. For instance, 
areA deletion strains of Fusarium verticillioides are not able to produce 
fumonisins on mature maize kernels. In Acremonium chrysogenum, the 
deletion of areA resulted in the reduction of cephalosporin because 
of a reduced expression of the enzymes involved in cephalosporin bi-
osynthesis. additionally, area is a positive regulator of the produc-
tion of gibberellins, trichothecene deoxynivalenol (DoN), fusarielin h, 
beauvericin and zearalenone (li et al., 2013; Tudzynski, 2014; knox 
and keller, 2015). The carbon catalytic repressor Crea also influences 
secondary metabolism. Crea is a Cys2his2 zinc finger transcription fac-
tor that is involved in the repression of genes associated with the use 
of carbon sources other than glucose (knox and keller, 2015). This 
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for specific binding sites (5′-SyGGrG-3′) and by direct interaction with 
activators (Janus et al., 2008). In P. chrysogenum Crea represses peni-
cillin biosynthesis and causes a reduced expression of the pcbAB gene 
that encodes nonribosomal peptide synthetase involved in this path-
way. Mutations in the putative Crea binding site in the pcbAB promoter 
result in enhanced enzyme expression when cells are grown in the pres-
ence of glucose (Cepeda-García et al., 2014). In contrast, mutations in 
the Crea binding sites of the ipnA promoter (pcbC in other species) of 
A. nidulans revealed that in this organism repression of penicillin bio-
synthesis by glucose is independent of Crea (knox and keller, 2015). 
Crea has been implicated in the variable metabolite profiles when fungi 
are grown in the presence of different carbon sources (yu and keller, 
2005). recently, the xylanase promoter binding protein (Xpp1) of Tricho-
derma reesei was used as a reporter to fulfil a dual role in the regulation 
of primary and secondary metabolism. Xpp1 is an activator of primary 
metabolism, while its deletion boosts the production of secondary me-
tabolites, including sorbicillinoids (Derntl et al., 2017). another Cis2his2 
zinc finger transcription factor conserved in fungi is PacC, which is in-
volved in ph dependent regulation. Deletion of the orthologue of this 
gene ( BbpacC) in Beauveria bassiana resulted in a loss of dipicolinic acid 
(insecticide compound) and oxalic acid production, compounds that re-
duce the ph of the medium. however, also production of a yellow pig-
ment was noted. When A. nidulans is grown at alkaline ph, PacC modu-
lates the expression of the acvA (pcbAB) and ipnA of the penicillin BGC, 
while it acts negatively on the expression of the sterigmato cystin BGC 
(Deepika et al., 2016; luo et al., 2017). In filamentous fungi, another 
global regulatory element is the CCaaT-binding complex (CBC). This 
complex consists of three proteins (hapB, hapC and hapE) that re-
spond to redox stimuli and an additional unit hapX, a bZIP protein that 
interacts with the complex for modulating the iron levels. In A. nidulans 
this complex binds to CaaTT motifs, which are present in the penicil-
lin BGC stimulating the expression of the ipnA and aatA (penDE) genes 
(Bayram and Braus, 2012; Brakhage, 2012). Whereas in F. verticillioides 
the orthologue core of this complex (FvhaP2, FvhaP3, and FvhaP5) is 
deleted, cells show an altered hyphal morphology, reduction of growth, 
reduced pathogenesis and a deregulation of secondary metabolism 
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IV.2.2 MANIPULATION OF SPECIFIC REGULATORS 
In addition to the global regulators, BGCs can be also modulated by 
specific regulatory elements, which most of the times are encoded by 
genes that are part of the same cluster that they regulate. In some cases, 
such regulators also influence the expression of other BGCs. It is esti-
mated that around 60 % of the fungal BGCs contain a putative regula-
tor. With PkS containing BCGs this even amounts to 90 % and mostly 
concerns a regulator that belongs to the Zn2Cys6 binuclear cluster do-
main family. With NrPS containing BGCs, the putative transcription 
factors are more diverse. The Zn2Cys6 family of transcription factors 
contain a DNa binding domain (DBD) that has two zinc atoms coordi-
nated by six cysteines. There are three sub regions: a linker, a zinc finger 
and a dimerization domain. additional to DBD, these proteins contain 
two further functional domains, the acidic region and the regulatory 
domain. These transcription factors can act as monomers, heterodi-
mers and homodimers. They recognize single or multiple trinucleotide 
sequences, commonly CCG triples, in a symmetric or asymmetrical for-
mat. The affinity of the DBD for a given DNa stretch is also determined 
by the nucleotides surrounding this triplet. The transcriptional activity 
of these proteins is regulated by phosphorylation, exposing the acti-
vation and DNa binding domains for DNa binding (MacPherson et al., 
2006; Brakhage, 2012). Some of these regulators have been shown 
to control the expression of BCGs. For instance, in Fusarium verticil-
lioides the disruption of FUM21 gene, that encodes a Zn2Cys6 protein, 
reduces fumonisin production as a result of a downregulation of the 
BGC (Brown et al., 2007). Interestingly, fumonisin production is also 
regulated by another Zn2Cys6 protein that is encoded by a gene located 
outside of the fumonisin cluster (Flaherty and Woloshuk, 2004). Mlcr 
is another example of a positive regulator that controls compactin pro-
duction in P. citrum (y. abe et al., 2002). aflr is a Zn2Cys6 protein that 
regulates the biosynthesis of aflatoxin/sterigmato cystin through bind-
ing to a palindromic sequence (5′-TCG(N5)GCa) that is found in most of 
the promoters of this BGC, albeit a second binding sequence has been 
reported that is associated with the autoregulation mechanism of the 
expression of AflR. The disruption of AlfR abolishes the production of 
aflatoxin/sterigmato cystin. likewise, some BGCs encode multiple reg-
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the aflS (formerly aflJ) gene. The corresponding transcription factor 
binds to aflr to enhance the transcription of early and mid- biosynthetic 
genes in the aflatoxin pathway (Georgianna and Payne, 2009; yin and 
keller, 2011). In P. chrysogenum and Trichoderma reesei, the sorbicillin 
BGC is regulated by two transcriptional factors through a coordinated 
action. also, regulation of BGCs via crosstalk has been observed in fila-
mentous fungi. For instance, the alcohol dehydrogenase promoter has 
been used to induce the expression of putative pathway-specific reg-
ulatory gene (scpR) in A. nidulans, which controls the expression of two 
pathway associated NrPS genes (inpA and inpB). Surprisingly, two PkS 
genes (afoE and afoG) and one transcriptional activator (afoA) belong-
ing to the asperfuranone BCG are also upregulated by Scpr, allowing 
the production of asperfuranone (Bergmann et al., 2010). For some 
regulators, no clear phenotype is observed. For instance deletion of 
the chyR gene of the chrysogine BGC in P. chrysogenum, has no effect 
on the expression of the corresponding BGC (Viggiano et al., 2017).
IV.2.3	 CHROMATIN-MEDIATED	REGULATION.	
In the cell, the DNa is wrapped in a complex of DNa, histone proteins 
and rNa called chromatin. This structure presents a basic unit de-
nominated nucleosome, which consists of superhelical DNa (147 base 
pairs) that rolls up an octamer of four different core histone proteins 
(two each of h2a, h2B, h3 and h4) in 1.75 turns. It has been shown 
that modifications of the chromatin structure (boosts or alters) changes 
gene expression, amongst others of genes involved in the biosynthesis 
of secondary metabolites. Structurally, chromatin represents an obsta-
cle that complicates access of DNa-binding factors to their correspond-
ing binding regions. according to the compaction level, chromatin can 
be in a dense (heterochromatin) or relaxing (euchromatin) state. These 
compaction levels are regulated by post-translational modification of 
the histone proteins by acetylation, methylation, ubiquitination, eth-
ylation, propylation, butylation and phosphorylation events. regions 
that display low transcriptional activity have been associated with the 
heterochromatic conformation. In contrast, the euchromatic conforma-
tion is present in regions with abundant coding sequences and is usu-
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hyper-acetylated nucleosomal histones. likewise, it has been reported 
that methylation of h3k9, h3k27 and h4k20 are typical markers of 
the heterochromatin, while in euchromatin methylation occurs at h3k4 
(Brosch et al., 2008; Strauss and reyes-Dominguez, 2011; Gacek and 
Strauss, 2012; Spraker and keller, 2014; rutledge and Challis, 2015). 
Histone	methylation,	acetylation	and	sumoylation. as mentioned above, 
laea influences secondary metabolite production through chroma-
tin modification. The methylation state of h3k9 has been correlated 
with heterochromatin protein a (hepa), since this protein needs the 
di- and tri-methylation of h3k9 for binding to chromatin and to form 
heterochromatin. Deletion of laea allows the unobstructed binding 
of hepa to the AlfR promoter, thereby affecting the expression of the 
sterigmatocystin pathway. The deletion of the methyltransferase en-
coding clrD and ezhB genes in Epichloe festucae, that act on h3k9 and 
h3k27, respectively (in axenic culture), results in the activation of 
the ergot alkaloids and lolitrem BCGs. These compounds are neces-
sary to stablish a symbiotic association with the plant Lolium perenne. 
Compass (complex of proteins associated with Set1) which methyl-
ates h3k4 in yeast, also impacts secondary metabolism in filamen-
tous fungi. The deletion of one of its components (cclA) in A. nidulans 
allowed the activation of a cryptic BCG and the production of emodin 
(Palmer and keller, 2010; Gacek and Strauss, 2012; Chujo and Scott, 
2014; Netzker et al., 2015; Deepika et al., 2016). likewise, in Fusarium 
fujikuroi and Fusarium graminearum, the deletion of cclA caused the 
overproduction of secondary metabolites derived from BCGs close to 
the telomeres, but this seems to relate to a h3k4 methylation inde-
pendent mechanism (Studt et al., 2017). other types of histone modi-
fication may alter the chromatin landscape, such as acetylation which 
is a reversible process governed by two antagonist enzymes: histone 
acetyltransferases (haTs) and histone deacetylases (hDaCs). active 
transcription is usually associated with histone acetylation, although 
recently the deacetylation of histones has been shown to cause acti-
vation of genes (Brosch et al., 2008). Usually, histones are acetylated 
by several complexes with acyltransferase activity, such as Saga/ada 
and Nua4. In A. nidulans a chromatin immunoprecipitation (ChIP) anal-
ysis revealed that GcnE and adaB, the catalytic subunits of the com-
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et al., 2016). Indeed, the interaction between A. nidulans and Strep-
tomyces rapamycinicus can be linked to a GcnE dependent increase 
in the acetylation of h3k14 that shields the promoters of the orsell-
inic acid BGC. The Saga/ada complex is a key player in the induction 
of the penicillin, terrequinone and sterigmatocystin BGCs (Nutzmann 
et al., 2011; Brakhage, 2012). In contrast, deletion of hdaA (encoding a 
hDaC) in A. nidulans resulted in major changes in the metabolite pro-
file (rutledge and Challis, 2015). hdaa is a class 2 histone deacetylase 
involved in the regulation of BGCs that are located near the telomeres, 
such as the penicillin and sterigmatocystin clusters in A. nidulans. In-
deed, deletion of hdaA gene results in the increased and early gene 
expression of these two BGCs, and the production of the correspond-
ing secondary metabolites. In A. fumigatus, the hdaA gene is involved 
in growth and production of secondary metabolites, and the deletion 
of this gene increases the production of many secondary metabolites 
while it causes a reduction of gliotoxin production. In contrast, hdaa 
overexpression shows the opposite effect.
hDaCs are ubiquitously distributed in filamentous fungi, and there-
fore hDaC inhibitors can be used to improve the synthesis of natu-
ral products by epigenome manipulation (Shwab et al., 2007; lee et al., 
2009). For instance, the metabolite profile of Cladosporium cladospori-
oides and A. niger underwent a significant change when these strains 
were exposed to suberoylanilide hydroxamic acid (Saha), a hDaC in-
hibitor, allowing the detection of two new compounds, cladochrome and 
nygerone a, respectively (rutledge and Challis, 2015). an exploratory 
analysis performed in twelve fungi treated with different types of DNa 
methyltransferase and histone deacetylase inhibitors, revealed the pro-
duction of new secondary metabolites but also the elevated amounts of 
known compounds (Williams et al., 2008). In this respect, the chroma-
tin state can directly influence the binding of transcription factors, and 
thereby modulate expression (Palmer and keller, 2010; Macheleidt et al., 
2016). It has been hypothesized that histone sumoylation may mod-
ulate secondary metabolite production. This process is mediated by a 
small protein termed SUMo (small ubiquitin-like modifier) that shares 
structural similarity to the ubiquitin protein. In A. nidulans, deletion of 
the sumO gene enhanced the production of asperthecin, whereas syn-
thesis of austinol, dehydroaustinal and sterigmatocystin was reduced. 
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thought that sumoylation acts at several levels, such as on epigenetic 
regulators (CoMPaSS, Clr4, SaGa/aDa and hDaCs) or at the level of 
transcriptional regulators (Brakhage and Schroeckh, 2011; Spraker and 
keller, 2014; Wu and yu, 2015).
Other	targets	for	regulation. Secondary metabolites produced by fungi 
can be toxic for themselves. Thus, it is not surprising that fungi have 
detoxification mechanisms. one of these mechanisms is toxin excre-
tion by transporters, which are membrane proteins whose genes of-
ten localize to the BGCs. Transporters may belong to different protein 
families but the major facilitator superfamily (MFS) and aBC super-
family are most commonly encoded by BGCs (keller, 2015). Since bi-
osynthesis of secondary metabolites may take place in different cell 
compartments, also intracellular transport may be evident (kistler and 
Broz, 2015). Despite their assumed biological importance, the deletion 
of transporter genes from the BGCs often does not impact secondary 
metabolite production. For instance, deletion of the A. paraisticus aflT 
gene, that encodes a MFS transporter, does not result in reduced afla-
toxin excretion, despite the fact that aflT belongs to the aflatoxin BCG 
and its expression is regulated by a specific transcription factor, aflr, of 
the pathway. Probably, this protein is redundant, and other transporters 
may participate in excretion, detoxification of self-defense. In A. fumig-
atus, Glia facilitates the excretion of gliotoxin. Similarly, the tri12 gene 
contained in the trichothecene BGC encodes for a membrane protein 
required for the biosynthesis of tricothecene and virulence of Fusarium 
graminearum on wheat crops (Chang et al., 2004; Menke et al., 2012; 
Wang et al., 2014; keller, 2015). often, however, the deletion of the 
transporter gene in BGCs has no effect on production. Possibly, these 
metabolites are also recognized by other promiscuous transporters, or 
transporters that are not part of the BGC (keller, 2015). For example, 
Zra1 of Gibberella zae, whose gene is not localized to the zearalenona 
BGC, impacts zearalenone production. however, the expression of the 
zra1 gene is regulated by the transcriptional factor ZEB2, whose gene 
localizes to the corresponding BGC (lee et al., 2011). also, the penicil-
lin BGC of P. chrysogenum lacks a transporter gene whereas export of 
penicillin occurs against the concentration gradient, probably through 
the activity of multiple transporter proteins (van den Berg et al., 2008; 
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IV.3 GENETIC ACTIVATION OF BGCS 
Several approaches have been used to activate the expression of cryp-
tic BGCs in a targeted manner. Usually, this is achieved by manipulation 
of pathway-specific regulatory genes, or by replacing endogenous pro-
moters for inducible systems (rutledge and Challis, 2015). The various 
approaches are described following and summarized in Figure 3. 
Gene	 deletion. It is a classical strategy that consists in the abolish-
ment of the expression of a certain gene by its elimination where-
upon the impact on the metabolite profile is examined by hPlC or 
lC-MS. a major limitation of this approach is that it can only be used 
in BGCs that are not totally silenced under laboratory condition. Us-
ing this strategy, it was possible to elucidate the highly branched bio-
synthetic pathway for the synthesis of roquefortine in P. chrysogenum 
(ali et al., 2013; ries et al., 2013; Deepika et al., 2016). likewise, this 
approach can be used to remove transcriptional repressor genes, as in 
the case of Tetr-like pathway-specific repressor proteins, whose dele-
tion induced the production of gaburedins in Streptomyces venezualae 
( rutledge and Challis, 2015). Global regulators, such as laea have also 
been targeted using this strategy (Chiang et al., 2009).
Promoter replacement. another method concerns the replacement of 
the endogenous promoter of the gene(s) in a BGC by a strong con-
stitutive or inducible promoter. For instance in A. nidulans replace-
ment of the native promotor of the scpR gene (secondary metabo-
lism cross-pathway regulator) for the inducible promoter of alcohol 
dehydrogenase alca induced the expression of a silent cluster that 
contained two NrPS genes (inpA and inpB) and scpR itself. addition-
ally, it also led to the expression of the asperfuranone BGC, which 
is normally silent (Bergmann et al., 2010; yin and keller, 2011; lim 
et al., 2012).
Overexpression	of	a	specific	or	global	regulator. This approach is one of 
the most used strategies to turn on cryptic BGCs, since a change in 
expression level of a regulator may boost the expression of a whole 
cluster. Usually, this strategy is applied in combination with the pro-
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of the transcription activator apdr under control of the alcohol de-
hydrogenase promoter alcAp, it has been possible to induce the ex-
pression of a hybrid PkS-NrPS BGC in A. nidulans. This resulted in the 
production of aspyridones a and B (Bergmann et al., 2007). Similarly 
when the global regulator FfSge, which is associated with vegetative 
growth of Fusarium fujikuroi, is overexpressed, some BGCs are forced 
to express under these unfavorable conditions (low nitrogen concen-
trations) leading to the identification of the corresponding products 
(Michielse et al., 2015). 
Modification	of	the	chromatin	landscape. Many fungal BCGs are located 
in distal regions of the chromosomes. In these rich heterochroma-
tin regions, transcription of the BGCs can be activated by epigenetic 
regulation. Therefore, the encoding genes of proteins that influence 
histone modification are prime targets, although these modifications 
can also be achieved by chemical treatment (Williams et al., 2008; 
 Brakhage, 2012). 
Heterologous	 expression	 and	 Refactoring. Due to the broad range of 
molecular tools available to express heterologous pathways in yeast, 
several attempts have been undertaken to express NrPS and PkS 
gene with the remainder of the pathway in yeast. however, the main 
obstacle is the large size (>40kb) of the DNa fragment that needs to 
be cloned, the effective activation/maturation of the expressed en-
zymes, and the toxicity of the produced compounds. alternatively, 
fungi may be used as platform organism, as for instance it was demon-
strated with the reconstruction of the citrinin gene cluster of Monas-
cus purpurea in A. oryzae. however, the revolutionary introduction of 
new genetic tools, such as CrISPr/Cas9 offers more effective solu-
tions to express specific BGCs. Such methods can contribute to prod-
uct identification but also to the production of unique compounds by 
introduction of specific tailoring enzymes. These are the main strate-
gies that are used for the activation of silent BGCs or for the modifica-
tion/redirection of known biosynthetic pathways in order to increase 
product diversification (Spraker and keller, 2014; rutledge and Challis, 
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V. SCOPE OF THE THESIS
This thesis examines the activation of the cryptic sorbicillin gene clus-
ter of an industrial strain of Penicillium chrysogenum to elucidate the 
sorbicillin biosynthesis pathway and regulation mechanism. 
Chapter 1 presents an overview of secondary metabolism in filamen-
tous fungi, describes the domain organization of core secondary me-
tabolite enzymes in particular polyketide synthases, and lists main 
strategies to activate the expression of so-called silent BGCs. In ad-
dition, it discusses regulation mechanisms in biosynthetic pathways.
Chapter 2 describes the identification of a polyketide synthase (Sora) 
involved in sorbicillin biosynthesis in P. chrysogenum. Through the re-
pair of a critical point mutation in the sorA gene, acquired during the 
CSI program, sorbicillin production was restored.
Chapter 3 describes the elucidation of the sorbicillin biosynthetic 
pathway through individual deletion of each gene of the BGC involved 
in this process. Through metabolic profiling of individual mutants the 
pathway was deduced, and a novel auto-induction mechanism for reg-
ulation of the sorbicillin pathway was resolved.
Chapter 4 shows the effect of the hdaa orthologue in the expression 
of secondary metabolite associated genes. Using a transcriptional and 
metabolic profiling, it was demonstrated that hdaa has a broad im-
pact in the regulation of the secondary metabolism, a direct influence 
in the spore pigmentation and gives evidence of a cross-talk event be-
tween gene clusters.
Chapter 5 presents an exploratory analysis of seven transporter pro-
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